<html><body><h2>Case: 1305831815482</h2>
<patient name=1075459>
68.0 year old White_Non-Hispanic Female
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">68</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">Calcium</td><td width="200">10</td><td width="200">1968-4-19</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">92</td><td width="200">1968-4-19</td></tr>
<tr><td width="200">Glucose</td><td width="200">139</td><td width="200">1966-3-11</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">4</td><td width="200">1964-8-18</td></tr>
<tr><td width="200">LDL_Cholesterol</td><td width="200">89</td><td width="200">1967-6-25</td></tr>
<tr><td width="200">Chloride</td><td width="200">98.0</td><td width="200">1968-4-19</td></tr>
<tr><td width="200">HDL_Cholesterol</td><td width="200">51</td><td width="200">1967-6-25</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">73</td><td width="200">1968-6-18</td></tr>
<tr><td width="200">BNP</td><td width="200">1,446</td><td width="200">1966-10-19</td></tr>
<tr><td width="200">Weight</td><td width="200">317</td><td width="200">1968-4-19</td></tr>
<tr><td width="200">HbA1C</td><td width="200">6</td><td width="200">1967-10-15</td></tr>
<tr><td width="200">Triglycerides</td><td width="200">153</td><td width="200">1967-6-25</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">172</td><td width="200">1967-6-25</td></tr>
<tr><td width="200">SGOT</td><td width="200">24</td><td width="200">1968-4-19</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">138</td><td width="200">1968-6-18</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">0</td><td width="200">1968-4-19</td></tr>
<tr><td width="200">Height</td><td width="200">64</td><td width="200">1966-10-19</td></tr>
<tr><td width="200">Potassium</td><td width="200">4</td><td width="200">1968-4-19</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">172</td><td width="200">1967-6-25</td></tr>
<tr><td width="200">BUN</td><td width="200">19</td><td width="200">1968-4-19</td></tr>
<tr><td width="200">HCT</td><td width="200">40</td><td width="200">1968-6-18</td></tr>
<tr><td width="200">HGB</td><td width="200">14</td><td width="200">1968-6-18</td></tr>
<tr><td width="200">Sodium</td><td width="200">132</td><td width="200">1968-4-19</td></tr>
<tr><td width="200">Albumen</td><td width="200">4</td><td width="200">1968-4-19</td></tr>
<tr><td width="200">Creatinine</td><td width="200">0.9</td><td width="200">1968-4-19</td></tr>
<tr><td width="200">Glycosylated_Hemoglobin</td><td width="200">6</td><td width="200">1967-10-15</td></tr>
<tr><td width="200">Pulse</td><td width="200">58</td><td width="200">1968-6-18</td></tr>
<tr><td width="200">PLT</td><td width="200">235</td><td width="200">1968-6-18</td></tr>
<tr><td width="200">WBC</td><td width="200">10</td><td width="200">1968-6-18</td></tr>
<tr><td width="200">eGFR</td><td width="200">40</td><td width="200">1968-4-19</td></tr>
<tr><td width="200">target_HBA1c</td><td width="200">7.0</td><td width="200">1967-5-15</td></tr>
<tr><td width="200">SGPT</td><td width="200">28</td><td width="200">1968-4-19</td></tr>
<tr><td width="200">B 12</td><td width="200">>1000</td><td width="200">1968-6-19</td></tr>
<tr><td width="200">Sex</td><td width="200">Female</td><td width="200"></td></tr>
<tr><td width="200">Race</td><td width="200">White_Non-Hispanic</td><td width="200"></td></tr>
<tr><td width="200">Obstructive_Pulmonary_Disease</td><td width="200"></td><td width="200">1968-5-11</td></tr>
<tr><td width="200">DM-Type2</td><td width="200"></td><td width="200">1967-5-15</td></tr>
<tr><td width="200">Hypertension</td><td width="200"></td><td width="200">1968-1-30</td></tr>
<tr><td width="200">diarrhea</td><td width="200"></td><td width="200">1967-2-9</td></tr>
<tr><td width="200">Depression</td><td width="200"></td><td width="200">1968-5-11</td></tr>
<tr><td width="200">Atrial_Fibrillation</td><td width="200"></td><td width="200">1968-5-11</td></tr>
<tr><td width="200">Anxiety</td><td width="200"></td><td width="200">1968-5-11</td></tr>
</table>
<p><b>Medications:</b> aspirin(325.0) labetalol(400.0) losartan(100.0) metformin(500.0) atorvastatin(10.0) nitrate(15.0) hydrochlorothiazide(25.0) furosemide(40.0) Insulin(0.04) amiodarone(200.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Laboratory_Test_Result_Syndrome</td>
<td width="200"></td>
<td width="200"> hyperglycemia[Glucose(139.0/1966-3-11)]()</td></tr>
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> hyponatremia[Sodium(132.0/1968-4-19)]()</td></tr>
<tr><td width="200">Target_Organ_Damage_Clinical_Cardiovascular_Disease</td>
<td width="200"></td>
<td width="200"> TOD/CCD[Presence of CKD (lab or ICD9)]()</td></tr>
<tr><td width="200">ACE I adverse reaction</td>
<td width="200"></td>
<td width="200"> Adverse reaction to ACE Inhibitor[ADR for ACEI]()</td></tr>
<tr><td width="200">On Amiodarone</td>
<td width="200"></td>
<td width="200"> Amiodarone[amiodarone]()</td></tr>
<tr><td width="200">DM (2ary prev)  BP controlled</td>
<td width="200"></td>
<td width="200"> Diabetes (Secondary Prevention)[Treatment_Diastolic_BP(73/null) && Treatment_Systolic_BP(138/null) && presence of diabetes mellitus]()</td></tr>
<tr><td width="200">Major Cardiovascular Risk Factor</td>
<td width="200"></td>
<td width="200"> Major Cardiovascular Risk Factor[Sex(Female) && Age(68.0/1970-1-1)]()</td></tr>
<tr><td width="200">CKD by eGFR</td>
<td width="200"></td>
<td width="200"> CKD by eGFR[eGFR(40.0/1968-4-19)]()</td></tr>
<tr><td width="200">CKD by eGFR or ICD9 codes</td>
<td width="200"></td>
<td width="200"> CKD[eGFR(40.0/1968-4-19)]()</td></tr>
<tr><td width="200">On meds & Presence of strong contraindication to HCTZ or using bad drug partner</td>
<td width="200"></td>
<td width="200"> Hypertension[taking furosemide && Antihypertensive_Agents]()</td></tr>
<tr><td width="200">Active prescription for thiazide</td>
<td width="200"></td>
<td width="200"> active prescription for thiazide[presence of thiazide diuretics]()</td></tr>
<tr><td width="200">active prescription for furosemide</td>
<td width="200"></td>
<td width="200"> active prescription for furosemide[taking furosemide]()</td></tr>
<tr><td width="200">Age > 65</td>
<td width="200"></td>
<td width="200"> age > 65 years[Age(68.0/1970-1-1)]()</td></tr>
<tr><td width="200">on >= 1 med</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">taking >= 2 anti hypertensive meds</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">Presence of adverse reaction to ACE</td>
<td width="200"></td>
<td width="200"> Presence of adverse reaction to ACE[Adverse Reaction to ACEI]()</td></tr>
<tr><td width="200">drug intolerance ACE/ARB OR hypotension OR renal insufficiency</td>
<td width="200"></td>
<td width="200"> drug intolerance ACE/ARB OR hypotension OR renal insufficiency[Adverse Reaction to ACEI]()</td></tr>
<tr><td width="200">Absence of Stage D HF</td>
<td width="200"></td>
<td width="200"> Absence of Stage D HF[Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF)]()</td></tr>
<tr><td width="200">High Risk for HF and DM, HTN, or atherosclerotic vascular disease</td>
<td width="200"></td>
<td width="200"> High Risk for HF and DM, HTN, or atherosclerotic vascular disease[diabetes_mellitus && Absence of HF]()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1968-05-11</td>
<td width="200"> Atrial_Fibrillation()</td></tr>
<tr><td width="200">Hypertension_Inclusive</td>
<td width="200">1968-01-30</td>
<td width="200"> Hypertension()</td></tr>
<tr><td width="200">Psychiatric_Diseases</td>
<td width="200">1968-05-11</td>
<td width="200"> Anxiety()</td></tr>
<tr> <td width="200"></td>
<td width="200">1968-05-11</td>
<td width="200"> Depression()</td></tr>
<tr><td width="200">Endocrine_Diseases</td>
<td width="200">1967-05-15</td>
<td width="200"> DM-Type2()</td></tr>
<tr><td width="200">Respiratory_Diseases</td>
<td width="200">1968-05-11</td>
<td width="200"> Obstructive_Pulmonary_Disease()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200">1967-02-09</td>
<td width="200"> diarrhea()
<tr> <td width="200"></td>
<td width="200">1968-06-19</td>
<td width="200"> B 12()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
<p><b>Allergies and Adverse Reactions:</b> <ul>
<li>Substance: lisinopril Reaction: 
<li>Substance: lisinopril Reaction: 
 </ul>
</patient>
<h1 align="center">ATHENA Heart Failure Guideline</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA Heart Failure Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF))</i>]
</ul>
<b>Scenario choice:</b> Stage A HF
<b>Scenario choice:</b> Stage C HF
<p>
<b>Goal:</b> SBP < 140 and DBP < 80(presence of diabetes mellitus)
<p><b>Reached goal?</b> achieved(Treatment_Diastolic_BP(73/null) && Treatment_Systolic_BP(138/null))
<p>
<b>Goal:</b> LDL< 100 mg/dL(CHD Risk Equivalent)
<p><b>Reached goal?</b> achieved(LDL_Cholesterol(89.0/1967-6-25))
<p><b>Messages by Types</b>
<ul>
<li><b>Class I</b>
<ul>
<li>Patients at high risk for developing HF should be counseled to avoid behaviors that may increase the risk of HF (e.g., smoking, excessive alcohol consumption, and illicit drug use). (Level of
Evidence: C)
<li>Healthcare providers should perform periodic evaluation for signs
and symptoms of HF in patients at high risk for developing HF.
(Level of Evidence: C)
<li>For patients with diabetes mellitus (who are all at high risk for developing HF), blood sugar should be controlled in accordance with contemporary guidelines. (Level of Evidence: C)
<li>Ventricular rate should be controlled or sinus rhythm restored in
patients with supraventricular tachyarrhythmias who are at high
risk for developing HF. (Level of Evidence: B)
</ul>
<li><b>Class III</b>
<ul>
<li>Routine use of nutritional supplements solely to prevent the development of structural heart disease should not be recommended for patients at high risk for developing HF. (Level of
Evidence: C)
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>Stage A messages</b><br>
<ul>
<li><b>behavior control <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</i>)])
Patients at high risk for developing HF should be counseled to avoid behaviors that may increase the risk of HF (e.g., smoking, excessive alcohol consumption, and illicit drug use). (Level of
Evidence: C)
<li><b>Periodic evaluation <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</i>)])
Healthcare providers should perform periodic evaluation for signs
and symptoms of HF in patients at high risk for developing HF.
(Level of Evidence: C)
<li><b>Blood sugar control <font color=FF0000>preferred</font></b>(rule in criterion<i> diabetes_mellitus</i> evaluate to <b> true</b> because <i>diabetes_mellitus</i>)])
For patients with diabetes mellitus (who are all at high risk for developing HF), blood sugar should be controlled in accordance with contemporary guidelines. (Level of Evidence: C)
<li><b>Ventricular rate/sinus rhythm  control <font color=FF0000>preferred</font></b>(rule in criterion<i> Presence of supraventricular tachyarrhythmias</i> evaluate to <b> true</b> because <i>Presence of supraventricular tachyarrhythmias</i>)])
Ventricular rate should be controlled or sinus rhythm restored in
patients with supraventricular tachyarrhythmias who are at high
risk for developing HF. (Level of Evidence: B)
<li><b>not use nutritional supplements <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</i>)])
Routine use of nutritional supplements solely to prevent the development of structural heart disease should not be recommended for patients at high risk for developing HF. (Level of
Evidence: C)
</ul>
<li><b> </b><br>
<ul>
<li><b>stage A drug choices <font color=FF0000>preferred</font></b>(strict rule-in condition<i> DM or HTN or atherosclerotic vascular disease</i> evaluate to <b> true</b> because <i>diabetes_mellitus</i>)])

</ul>
</ul>
<b>Considerations for adding drug: </b><ul>
</ul>
</ul>
</ul>
</body></html>